相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea
Dong Hyun Sinn et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy
S. Mauss et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
Antonio Ascione et al.
GASTROENTEROLOGY (2010)
Randomized Study of Peginterferon-alpha 2a Plus Ribavirin vs Peginterferon-alpha 2b Plus Ribavirin in Chronic Hepatitis C
Maria Grazia Rumi et al.
GASTROENTEROLOGY (2010)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Disease progression and the risk factor analysis for chronic hepatitis C
Dong Hyun Sinn et al.
LIVER INTERNATIONAL (2008)
Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
Sharif Missiha et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
Mitchell L. Shiffman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Predictors of response of US veterans to treatment for the hepatitis C virus
Lisa I. Backus et al.
HEPATOLOGY (2007)
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy
DM Jensen et al.
HEPATOLOGY (2006)
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin
P Ferenci et al.
JOURNAL OF HEPATOLOGY (2005)
Current status of hepatitis C virus infection in Korea
DJ Suh et al.
INTERVIROLOGY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
GL Davis et al.
HEPATOLOGY (2003)
Industrial accident compensation insurance benefits on cerebrovascular and heart disease in Korea
HS Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
分享论文
